Skip to main content
Top
Published in: Malaria Journal 1/2011

Open Access 01-12-2011 | Research

Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia

Authors: Hailemariam Lemma, Curt Löfgren, Miguel San Sebastian

Published in: Malaria Journal | Issue 1/2011

Login to get access

Abstract

Background

In 2004, Ethiopia switched its first-line treatment of uncomplicated Plasmodium falciparum malaria from sulphadoxine-pyrimethamine to a fixed artemisinin-based combination therapy (ACT), artemether-lumefantrine (AL). Patient adherence to AL regimen is a major determining factor to achieve the desired therapeutic outcome. The aim of this study was to measure patient adherence levels to the six-dose AL regimen for the treatment of uncomplicated P. falciparum malaria and to identify its determinant factors in rural areas of the Tigray region, Ethiopia

Methods

The study was conducted under routine health service delivery at health posts level. Patients/caregivers were not informed about their home visit and were traced on the day after they finished the AL regimen. By combining the response to a structured questionnaire and the tablet count from the blister, adherence level was classified into three categories: definitely non-adherent, probably non-adherent and probably adherent. Reasons for being definitely non-adherent were also assessed. For the purpose of examine risk factors, definitely non-adherent and probably non-adherent was merged into a non-adherent group. Variables found significantly associated (p < 0.05) with the adherence level on the univariate analysis were fitted into a multivariate logistic regression model.

Results

Out of the total initially enrolled 180 patients, 86.1% completed the follow-up. Out of these, 38.7% were classified as probably adherent, 34.8% as probably non-adherent, and 26.5% were definitely non-adherent. The most common reasons that definitely non-adherents gave for not taking the full dose were "too many tablets" (37.3%) and to "felt better before finished the treatment course" (25.5%). The adherence of the patients was associated with the ownership of a radio (adjusted odd ratio, AOR: 3.8; 95% CI: 1.66-8.75), the belief that malaria can be treated traditionally (AOR: 0.09; 95% CI: 0.01-0.78) and a delay of more than one day in seeking treatment after the onset of fever (AOR: 5.39; 95% CI: 1.83-15.88).

Conclusion

The very low adherence to AL found in this study raises serious concerns for the malaria control in the region. The implementation of a monitoring adherence system is essential to ensure long-term treatment efficacy.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: World Malaria Report 2009. 2009, Geneva: The World Health Organization WHO: World Malaria Report 2009. 2009, Geneva: The World Health Organization
2.
go back to reference Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, Mulure N, Genton B: Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J. 2010, 9: 48-10.1186/1475-2875-9-48.PubMedCentralCrossRefPubMed Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, Mulure N, Genton B: Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J. 2010, 9: 48-10.1186/1475-2875-9-48.PubMedCentralCrossRefPubMed
3.
go back to reference FMOH: National Strategic Plan for Malaria Prevention, Control and Elimination in Ethiopia, 2010-2015 (2002/2003-2007/2008 EC). 2009, Addis Ababa: Federal Democratic Republic of Ethiopia, Ministry of Health FMOH: National Strategic Plan for Malaria Prevention, Control and Elimination in Ethiopia, 2010-2015 (2002/2003-2007/2008 EC). 2009, Addis Ababa: Federal Democratic Republic of Ethiopia, Ministry of Health
4.
go back to reference Population Census Commission: Summary and Statistical Report of The 2007 Population and Housing Census. 2008, Addis Ababa: Federal Democratic Republic of Ethiopia, Population Census Commission Population Census Commission: Summary and Statistical Report of The 2007 Population and Housing Census. 2008, Addis Ababa: Federal Democratic Republic of Ethiopia, Population Census Commission
5.
go back to reference FMOH: Malaria diagnosis and treatment a guideline for health workers in Ethiopia. 2004, Addis Ababa: Federal Democratic Republic of Ethiopia, Ministry of Health FMOH: Malaria diagnosis and treatment a guideline for health workers in Ethiopia. 2004, Addis Ababa: Federal Democratic Republic of Ethiopia, Ministry of Health
6.
go back to reference Omari AA, Gamble C, Garner P: Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria (Review). Cochrane Database Syst Rev. 2006, 2: Omari AA, Gamble C, Garner P: Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria (Review). Cochrane Database Syst Rev. 2006, 2:
7.
go back to reference Mulenga M, Van Geertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Overmeir C, Dujardin JC, D'Alessandro U: Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J. 2006, 5: 73-79. 10.1186/1475-2875-5-73.PubMedCentralCrossRefPubMed Mulenga M, Van Geertruyden JP, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Overmeir C, Dujardin JC, D'Alessandro U: Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malar J. 2006, 5: 73-79. 10.1186/1475-2875-5-73.PubMedCentralCrossRefPubMed
8.
go back to reference Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O: Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J. 2007, 6: 80-10.1186/1475-2875-6-80.PubMedCentralCrossRefPubMed Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O: Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J. 2007, 6: 80-10.1186/1475-2875-6-80.PubMedCentralCrossRefPubMed
9.
go back to reference Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007, 101: 344-350. 10.1016/j.trstmh.2006.06.010.CrossRefPubMed Fanello CI, Karema C, van Doren W, Van Overmeir C, Ngamije D, D'Alessandro U: A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Trans R Soc Trop Med Hyg. 2007, 101: 344-350. 10.1016/j.trstmh.2006.06.010.CrossRefPubMed
10.
go back to reference Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T: Therapeutic efficacy of Artemether/Lumefantrine (Coartem) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasites Vectors. 2010, 3: 1-10.1186/1756-3305-3-1.PubMedCentralCrossRefPubMed Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T: Therapeutic efficacy of Artemether/Lumefantrine (Coartem) against Plasmodium falciparum in Kersa, South West Ethiopia. Parasites Vectors. 2010, 3: 1-10.1186/1756-3305-3-1.PubMedCentralCrossRefPubMed
11.
go back to reference Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016/S0140-6736(05)66417-3.CrossRefPubMed Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016/S0140-6736(05)66417-3.CrossRefPubMed
12.
go back to reference Kremsner PG, Krishna S: Antimalarial combinations. Lancet. 2004, 364: 285-294. 10.1016/S0140-6736(04)16680-4.CrossRefPubMed Kremsner PG, Krishna S: Antimalarial combinations. Lancet. 2004, 364: 285-294. 10.1016/S0140-6736(04)16680-4.CrossRefPubMed
13.
go back to reference Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY: Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J. 2009, 8: 257-10.1186/1475-2875-8-257.PubMedCentralCrossRefPubMed Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY: Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J. 2009, 8: 257-10.1186/1475-2875-8-257.PubMedCentralCrossRefPubMed
14.
go back to reference Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope?. Bull World Health Organ. 2000, 78: 1378-1388.PubMedCentralPubMed Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope?. Bull World Health Organ. 2000, 78: 1378-1388.PubMedCentralPubMed
15.
go back to reference Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H: Chloroquine resistance of Plasmodium falciparum: a biological advantage?. Trans R Soc Trop Med Hyg. 1995, 89: 90-91. 10.1016/0035-9203(95)90672-X.CrossRefPubMed Wernsdorfer WH, Landgraf B, Wiedermann G, Kollaritsch H: Chloroquine resistance of Plasmodium falciparum: a biological advantage?. Trans R Soc Trop Med Hyg. 1995, 89: 90-91. 10.1016/0035-9203(95)90672-X.CrossRefPubMed
16.
go back to reference Wernsdorfer WH: Epidemiology of drug resistance in malaria. Acta Trop. 1994, 56: 143-56. 10.1016/0001-706X(94)90060-4.CrossRefPubMed Wernsdorfer WH: Epidemiology of drug resistance in malaria. Acta Trop. 1994, 56: 143-56. 10.1016/0001-706X(94)90060-4.CrossRefPubMed
17.
go back to reference White NJ, Olliaro PL: Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today. 1996, 12: 399-401. 10.1016/0169-4758(96)10055-7.CrossRefPubMed White NJ, Olliaro PL: Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today. 1996, 12: 399-401. 10.1016/0169-4758(96)10055-7.CrossRefPubMed
18.
go back to reference Bloland P: Drug resistance in malaria. 2001, Geneva: World Health Organization Bloland P: Drug resistance in malaria. 2001, Geneva: World Health Organization
19.
go back to reference WHO: Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring:1996-2004. WHO/HTM/MAL/2005.1103. 2005, Geneva: World Health Organization WHO: Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring:1996-2004. WHO/HTM/MAL/2005.1103. 2005, Geneva: World Health Organization
20.
go back to reference Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthman JP: Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, Southern Sudan. Ann Trop Med Parasitol. 98: 635-637. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthman JP: Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, Southern Sudan. Ann Trop Med Parasitol. 98: 635-637.
21.
go back to reference Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP: Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised rial. Lancet. 2005, 365: 1467-1473. 10.1016/S0140-6736(05)66416-1.CrossRefPubMed Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP: Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised rial. Lancet. 2005, 365: 1467-1473. 10.1016/S0140-6736(05)66416-1.CrossRefPubMed
22.
go back to reference Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria In Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria In Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed
23.
go back to reference Yeung S, White NJ: How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005, 10: 121-138. 10.1111/j.1365-3156.2004.01364.x.CrossRefPubMed Yeung S, White NJ: How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005, 10: 121-138. 10.1111/j.1365-3156.2004.01364.x.CrossRefPubMed
24.
go back to reference Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M: Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health. 2006, 11: 1003-1016. 10.1111/j.1365-3156.2006.01654.x.CrossRefPubMed Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M: Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health. 2006, 11: 1003-1016. 10.1111/j.1365-3156.2006.01654.x.CrossRefPubMed
25.
go back to reference Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F: Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J. 2008, 7: 6-10.1186/1475-2875-7-6.PubMedCentralCrossRefPubMed Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F: Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J. 2008, 7: 6-10.1186/1475-2875-7-6.PubMedCentralCrossRefPubMed
26.
go back to reference WHO: Deployment of artemetherlumefantrine with rapid diagnostic tests at community level, Raya Valley, Tigray, Ethiopia. 2009, Geneva: The World Health Organization WHO: Deployment of artemetherlumefantrine with rapid diagnostic tests at community level, Raya Valley, Tigray, Ethiopia. 2009, Geneva: The World Health Organization
27.
go back to reference THB: Tigray Health profile. 2008, Mekelle: Tigray Health Bureau THB: Tigray Health profile. 2008, Mekelle: Tigray Health Bureau
28.
go back to reference FMoH: Health Sector Strategic Plan (HSDP-III) 2005/6-2009/10. 2005, Addis Ababa: Federal Ministry of Health, Ethiopia FMoH: Health Sector Strategic Plan (HSDP-III) 2005/6-2009/10. 2005, Addis Ababa: Federal Ministry of Health, Ethiopia
29.
go back to reference FMoH: Health Extension Programme implementation guideline. 2004, Addis Ababa: Federal Ministry of Health, Ethiopia FMoH: Health Extension Programme implementation guideline. 2004, Addis Ababa: Federal Ministry of Health, Ethiopia
30.
go back to reference Fogg C: Adherence to 6-dose regime of Coratem (artemether + lumefantrine) in Mbarara, Uganda. 2003, Kampala: Epicentre, Paris, France; Médecins Sans Frontières, Paris, France; Mbarara University of Science and Technology, Mbarara, Uganda, 44- Fogg C: Adherence to 6-dose regime of Coratem (artemether + lumefantrine) in Mbarara, Uganda. 2003, Kampala: Epicentre, Paris, France; Médecins Sans Frontières, Paris, France; Mbarara University of Science and Technology, Mbarara, Uganda, 44-
31.
go back to reference Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D: Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health. 2004, 9: 62-67. 10.1046/j.1365-3156.2003.01157.x.CrossRefPubMed Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D: Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health. 2004, 9: 62-67. 10.1046/j.1365-3156.2003.01157.x.CrossRefPubMed
32.
go back to reference Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009, 8: 204-10.1186/1475-2875-8-204.PubMedCentralCrossRefPubMed Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009, 8: 204-10.1186/1475-2875-8-204.PubMedCentralCrossRefPubMed
33.
go back to reference Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, Bangali AM, Kamal AT, Karim J, Kaewkungwal J, Singhasivanon P: Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Trans R Soc Trop Med Hyg. 2008, 102: 861-867. 10.1016/j.trstmh.2008.05.022.CrossRefPubMed Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, Bangali AM, Kamal AT, Karim J, Kaewkungwal J, Singhasivanon P: Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Trans R Soc Trop Med Hyg. 2008, 102: 861-867. 10.1016/j.trstmh.2008.05.022.CrossRefPubMed
34.
go back to reference Paulander J, Olsson H, Lemma H, Getachew A, Sebastian M: Knowledge, attitudes and practice about malaria in rural Tigray, Ethiopia. Global Health Action. 2009, 2: Paulander J, Olsson H, Lemma H, Getachew A, Sebastian M: Knowledge, attitudes and practice about malaria in rural Tigray, Ethiopia. Global Health Action. 2009, 2:
35.
go back to reference Abdulla S, Sagara I: Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. Malar J. 2009, 8 (Suppl 1): S7-10.1186/1475-2875-8-S1-S7.PubMedCentralCrossRefPubMed Abdulla S, Sagara I: Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children. Malar J. 2009, 8 (Suppl 1): S7-10.1186/1475-2875-8-S1-S7.PubMedCentralCrossRefPubMed
36.
go back to reference Conteh L, Stevens W, Wiseman V: The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia. Trop Med Int Health. 2007, 12: 382-391. 10.1111/j.1365-3156.2006.01806.x.CrossRefPubMed Conteh L, Stevens W, Wiseman V: The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia. Trop Med Int Health. 2007, 12: 382-391. 10.1111/j.1365-3156.2006.01806.x.CrossRefPubMed
37.
go back to reference Yepez MC, Zambrano D, Carrasco F, Yepez RF: The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients. Rev Cubana Med Trop. 2000, 52: 81-89.PubMed Yepez MC, Zambrano D, Carrasco F, Yepez RF: The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients. Rev Cubana Med Trop. 2000, 52: 81-89.PubMed
Metadata
Title
Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia
Authors
Hailemariam Lemma
Curt Löfgren
Miguel San Sebastian
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2011
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-10-349

Other articles of this Issue 1/2011

Malaria Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.